ASA's 37th National Conference on Autism Spectrum Disorders (July 13-15, 2006)

    ASA Homepage
Thursday, July 13, 2006: 11:00 AM-12:15 PM
550 A-B
#2069- The Autism-Mercury Connection
We will provide an overview of the scientific data regarding the hypothesis that mercury poisoning is a possible cause of some cases of autism. This will include the sources of mercury, risk factors for mercury toxicity, evidence that many children with autism have a decreased ability to excrete mercury, evidence that children with autism have a higher body burden of mercury, and how to prevent and treat mercury poisoning.

Presenter:James Adams, Ph.D., Arizona State University, Professor - James B. Adams is a Professor at Arizona State University, president of the Phoenix Autism Society Chapter, and serves on the Autism Society Board of Directors. He has conducted research on the causes of autism and how to treat it, including nutritional deficiencies and treatments, toxic metals/chelation, and gut dysbiosis.
Session Content Plan: (Note: This is an update of my presentation in July 2005 at the ASA, as a great deal of new information is now available on the possible link between autism and mercury as well as information on new treatments for mercury toxicity).

Learning Objectives: 1) Learn the symptoms of infantile mercury toxicity, and the similarity to the symptoms of autism 2) Learn the major sources of exposure to mercury 3) Understand the factors that make some people more sensitive to mercury poisoning 4) Understand the scientific data that demonstrates high levels of mercury and other toxic metals in children with autism 5) Learn how to prevent mercury poisoning, and how to treat cases of it

Content: 1) Overview of the symptoms of infantile mercury toxicity, and their similarity to the symptoms of autism, based on the report of the Agency for Toxic Substances and Disease Registry (a branch of the CDC) and the article by Bernard et al in Medical Hypothesis.

2) Overview of the sources of exposure to mercury, including seafood, dental fillings, vaccines, power plants, and other sources. This will include a quantitative comparison of the amount and type of mercury exposure due to each source.

3) Explanation of the critical factors that make some people more sensitive to mercury poisoning, including: A) Antibiotics: A study of rats found that the half-life for excretion of mercury was increased from 10 days to 100 days during antibiotic usage. Our study and others have found that children with autism had a 5x higher exposure to oral antibiotics in early childhood, primarily due to ear infections. B) Low levels of sulfate/glutathione/metallothionein: glutathione and metallathionein are the primary mechanism for the excretion of mercury, and their level is highly dependent on sulfate status, which is very low in children with autism. C) Early exposure: Our study found that mothers of children with autism consumed twice the amount of seafood during pregnancy as the mothers of typical children, and this was confirmed by hair analysis which found twice as much mercury in the hair of mothers of children with autism.

4) Mercury in Baby Hair: A recent study found that children with autism have 1/8 the normal amount of mercury in their baby hair, suggesting an inhibited ability to excrete mercury which is consistent with their high oral antibiotic usage. Also, they found that the severity of autism had a strong inverse correlation with the hair level, such that the children with the lowest levels of mercury in their hair (least excretion) were the most severe. We will also report on our replication study, which we carried out with the help of NIH and researchers at MIT, and which generally supports the Holmes' et al study.

5) Baby Teeth: We will present our study with the Un. of Texas, which evaluated the level of mercury, lead, and zinc in the baby teeth of children with autism vs. controls, and found that children with autism have 3x as much mercury in their baby teeth.

6) Glutathione: We will briefly review the published study by Jill James, which found that children with autism have low levels of glutathione, which is required for excretion of mercury and other toxins, so it strongly suggests that children with autism have a decreased ability to excrete mercury.

7) Thimerosal Studies: We will review the 9 epidemiology studies which investigated the autism-thimerosal connection, including 4 that found a strong connection, one that was inconclusive, and four that failed to find a connection. We will also review the study by Hornig et al. which found that some genetically-susceptible strains of mice were injured by injections of thimerosal at the level used in childhood vaccines.

8) DMSA challenge results: DMSA is an FDA-approved medication for removing toxic metals from the body. We will present the results of our published study (led by Dr. Jeff Bradstreet) which found that DMSA results in significantly more excretion of heavy metals in children with autism vs controls. This is strong evidence that children with autism have excess amounts of heavy metals trapped in their body.

9) Treatment Reports: We will briefly mention the reports by clinicians on the effect of long-term DMSA treatments in hundreds of children with autism. We will also discuss two newer treatments, DMPS and TTFD, which are becoming more commonly used.

10) Treatment Study: We hope to be able to report on the results of our randomized, double-blind, placebo-controlled DMSA treatment study it was just funded and we hope to start soon.

11) Question/Answer period

See more of The ASA's 37th National Conference on Autism Spectrum Disorders (July 13-15, 2006)